News | Magnetic Resonance Imaging (MRI) | September 21, 2017

Systems designed to help clinicians deliver intelligent technology to enhance productivity and safety

Toshiba Showcases MRI Workflow Enhancements at RSNA 2017

September 21, 2017 — Toshiba Medical will highlight its latest magnetic resonance imaging (MRI) technology, led by the Vantage Titan/Zen Edition and Vantage Galan 3T, at the 2017 Radiological Society of North America (RSNA) annual meeting, Nov. 26-Dec. 1 in Chicago.

The Zen Edition highlights intelligent workflow and patient comfort, providing a complete clinical offering to help clinicians make accurate diagnoses. The system features patient comfort tools, including Pianissimo Zen, which makes scanning even more quiet by reducing sound during acquisition by 99 percent when mUTE or mUTE 4D-MRA sequences are used. Toshiba Medical’s newest clinical applications, including T1 mapping utilizing Modified Look Locker Inversion-Recovery (MOLLI) sequence, allow providers to acquire a more quantitative characterization of myocardial tissue within a single breath hold. To enhance cardiac imaging workflow, the system features multi-echo T2 Mapping with Toshiba Medical’s updated FFE2D mEcho sequence, which is used in quantification and analysis of myocardial iron overload.

The premium Vantage Galan 3T offers the ability to conduct quick, comfortable and high-quality neuro imaging exams. Designed to increase signal-to-noise ratio (SNR) by up to 20 percent, the system allows for faster sampling and higher-resolution images thanks to PURERF and Saturn technologies. This, combined with the ability to stack protocol sequences, results in quick neuro exams, enabling healthcare providers to produce higher resolution images for myriad neuro exams in under five minutes.* The system’s 71 cm aperture expands access to large and claustrophobic patients while offering non-contrast magnetic resonance angiography (MRA) sequences and Pianissimo Zen technology that reduces sound during acquisition by 99 percent. Additionally, the Vantage Galan 3T enhances diagnostic confidence with advanced clinical applications and helps make exams easy to perform with EasyTech workflow solutions, which streamline positioning and scanning. At RSNA, Toshiba Medical will showcase enhancements to the Galan that can increase resolution in diffusion weighted imaging.

For more information: www.medical.toshiba.com

* Initial indications suggest the following neuro sequences can be performed in under five minutes: SAG T1, AX T2, AX T2 FLAIR, AX T2* and AX DWI/ADC.


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Radiology Imaging

July 23, 2024 — EMVision, an Australian medical device company focused on the development and commercialization of ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Feature | SCCT | by Christine Book

June 27, 2024 — The countdown has begun for the Society of Cardiovascular Computed Tomography (SCCT) 19th Annual ...

Time June 27, 2024
arrow
News | Clinical Trials

June 27, 2024 — Prenuvo, which makes whole-body MRI screening for early cancer detection and other diseases, has ...

Time June 27, 2024
arrow
Subscribe Now